The expression levels of SETD2 in most tumors vs. normal tissues were downregulated, and SETD2 inhibits the growth of these tumor, for example, in lung adenocarcinoma 7 and in kidney cancer 11. This evidence concerns the gene SETD2 and lung adenocarcinoma.